Ronald E Gress
Overview
Explore the profile of Ronald E Gress including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
6115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holtzman N, Curtis L, Salit R, Shaffer B, Pirsl F, Ostojic A, et al.
Blood Adv
. 2024 Apr;
8(16):4294-4310.
PMID: 38669315
Chronic graft-versus-host disease (cGVHD) remains a significant problem for patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Although in vivo lymphodepletion for cGVHD prophylaxis has been explored in the myeloablative...
2.
Iwamura C, Ohnuki H, Flomerfelt F, Zheng L, Carletti A, Wakashin H, et al.
Nat Immunol
. 2023 Nov;
24(12):2080-2090.
PMID: 37957354
Aberrant differentiation of progenitor cells in the hematopoietic system is known to severely impact host immune responsiveness. Here we demonstrate that NOD1, a cytosolic innate sensor of bacterial peptidoglycan, also...
3.
Brender J, Assmann J, Farthing D, Saito K, Kishimoto S, Warrick K, et al.
Sci Rep
. 2023 Sep;
13(1):14699.
PMID: 37679461
In vivo deuterated water (HO) labeling leads to deuterium (H) incorporation into biomolecules of proliferating cells and provides the basis for its use in cell kinetics research. We hypothesized that...
4.
Li C, Kim H, Prakhar P, Luo S, Crossman A, Ligons D, et al.
Mucosal Immunol
. 2022 Jul;
15(5):882-895.
PMID: 35778600
The chemokine receptor CCR9 equips T cells with the ability to respond to CCL25, a chemokine that is highly expressed in the thymus and the small intestine (SI). Notably, CCR9...
5.
Voynova E, Hawk N, Flomerfelt F, Telford W, Gress R, Kanakry J, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158792
NK effector cells expressing a CAR construct may be used to target T-lineage markers. In this work, we compared the activity of a NK-specific CAR-NK and a CAR-T framework when...
6.
Williams K, Pavletic S, Lee S, Martin P, Farthing D, Hakim F, et al.
Transplant Cell Ther
. 2022 Feb;
28(5):264.e1-264.e9.
PMID: 35114411
Bronchiolitis obliterans syndrome (BOS) is a severe manifestation of chronic graft-versus-host disease (cGVHD) following hematopoietic cell transplantation (HCT). Montelukast interrupts cysteinyl leukotriene (CysLT) activity and may diminish the activation and...
7.
Park J, Won H, DiPalma D, Kim H, Kim T, Li C, et al.
Cell Rep
. 2022 Jan;
38(2):110219.
PMID: 35021100
Understanding the homeostatic mechanism of invariant natural killer T (iNKT) cells is a critical issue in iNKT cell biology. Because interleukin (IL)-15 is required for the thymic generation of iNKT...
8.
Won H, Kim H, Crossman A, Awasthi P, Gress R, Park J
Front Immunol
. 2021 May;
12:642856.
PMID: 34054809
Invariant NKT (NKT) cells are thymus-generated innate-like T cells, comprised of three distinct subsets with divergent effector functions. The molecular mechanism that drives the lineage trifurcation of immature NKT cells...
9.
Kovalovsky D, Yoon J, Cyr M, Simon S, Voynova E, Rader C, et al.
Leukemia
. 2021 Feb;
35(9):2581-2591.
PMID: 33633313
The only current curative treatment for chronic lymphocytic leukemia (CLL) is allogenic hematopoietic stem cell transplantation. Chimeric antigen receptor treatment targeting CD19 for CLL achieved some complete responses, suggesting the...
10.
Assmann J, Farthing D, Saito K, Maglakelidze N, Oliver B, Warrick K, et al.
Blood
. 2020 Aug;
137(1):126-137.
PMID: 32785680
Graft-versus-host disease (GVHD) is a prominent barrier to allogeneic hematopoietic stem cell transplantation (AHSCT). Definitive diagnosis of GVHD is invasive, and biopsies of involved tissues pose a high risk of...